Corvus Capital Ltd. → CONDUIT PHARMACEUTICALS INC. CDTTW

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

6 13D/G filings on this issuer

5 other filings besides this one

Filer Track Record

3 filings by this filer

2 other filings in the data moat

Short Interest · settle 2026-07-15

DTC 21.26

112,172 shares short · -0.3% vs prior

Other 13D/G Filings on CONDUIT PHARMACEUTICALS INC.

Filed	Form	Filer	Stake	Shares
2026-06-23	SCHEDULE 13D/A	Taylor Mark Andrew	—	0	view →
2026-06-05	SCHEDULE 13G	Ascent Partners Fund LLC	—	—	view →
2026-05-20	SCHEDULE 13G	Nirland Ltd	—	—	view →
2026-05-14	SCHEDULE 13D/A	Corvus Capital Ltd.	—	257,166	view →
2025-07-31	SCHEDULE	Corvus Capital Ltd.	6.00%	174,993	view →

Other Filings by Corvus Capital Ltd.

Filed	Form	Issuer	Stake	Shares
2026-05-14	SCHEDULE 13D/A	CDT Equity Inc. CDTTW	—	257,166	view →
2025-07-31	SCHEDULE	CONDUIT PHARMACEUTICALS INC. CDTTW	6.00%	174,993	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →